Corient Private Wealth’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.1K Buy
+20,232
New +$39.6K ﹤0.01% 3222

Other funds holding BDTX

Corient Private Wealth's BDTX Position: Q3 2026 in Review

Corient Private Wealth opened a new position in Black Diamond Therapeutics (BDTX) in Q3 2026: 20,232 shares worth $38.1K. The stake represents ﹤0.01% of the portfolio and ranks #3222 among its holdings.

111 funds tracked by Wall St. Rank hold BDTX as of Q3 2026.

  • Corient Private Wealth held 20,232 shares of Black Diamond Therapeutics worth $38.1K as of Q3 2026.
  • Black Diamond Therapeutics was a new Corient Private Wealth position in Q3 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #3222 holding.
  • 111 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2026.

Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.